- Home
- ATMU vs KNSA Comparison
ATMU vs KNSA Comparison
Compare ATMU & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATMU | KNSA |
|---|---|---|
| Founded | 1958 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.9B |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ATMU | KNSA |
|---|---|---|
| Price | $44.17 | $78.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $58.25 | ★ $60.86 |
| AVG Volume (30 Days) | ★ 495.2K | 415.4K |
| Earning Date | 05-01-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | 12.61 | ★ 225.00 |
| EPS | ★ 1.37 | 0.27 |
| Revenue | ★ $1,764,300,000.00 | $677,564,000.00 |
| Revenue This Year | $15.00 | $37.48 |
| Revenue Next Year | $5.13 | $17.87 |
| P/E Ratio | ★ $32.27 | $293.81 |
| Revenue Growth | 5.67 | ★ 60.09 |
| 52 Week Low | $42.60 | $35.33 |
| 52 Week High | $66.50 | $82.94 |
Technical Indicators
Market Signals| Indicator | ATMU | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 30.11 | 54.16 |
| Support Level | N/A | $44.95 |
| Resistance Level | $54.95 | $81.97 |
| Average True Range (ATR) | 1.37 | 2.39 |
| MACD | -0.24 | -0.39 |
| Stochastic Oscillator | 7.48 | 56.80 |
Price Performance
Historical ComparisonAbout ATMU Atmus Filtration Technologies Inc.
Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.